Prevention, diagnosis and treatment - three topics to explore and a chance to meet in Sofia.

RIDACOM will be taking part in the 5th National Conference on Vaccine-Preventable Diseases, held on November 6-8 at the National Center of Infectious and Parasitic Diseases (NCIPD) Auditorium in Sofia.

The conference brings together medical professionals from a range of specialties to discuss the prevention, diagnosis and treatment of vaccine-preventable diseases. This multidisciplinary event offers an opportunity to exchange experience and explore how scientific advances can help address the challenges encountered in everyday clinical practice.

Our focus is on innovative diagnostics, with technologies for pathogen detection, assessment of the immune response and testing at the point of care. Visit the RIDACOM exhibition area to explore the following solutions.

More insight from the initial assessment.

• Ozelle EHBT-50 brings the capabilities of a next-generation mini laboratory into a single compact instrument, combining hematology with 7-DIFF CBM analysis, biochemistry and immunoassay testing. AI-powered morphological analysis supports automated cell recognition and standardized classification of cell populations, while real-time quality control adds confidence in the results. Together, these capabilities help narrow the differential diagnosis from the first sample when an infection is suspected.
• Novatrend Plus AFR-600 is a compact, multiparameter POCT system for quantitative and qualitative fluorescence immunoassays, with a broad menu covering inflammatory, cardiac, endocrine, renal and infectious disease markers. It combines high analytical precision with automated result interpretation and turnaround times of just 3–15 minutes, bringing laboratory-level diagnostic capabilities to the point of care.

Timely diagnostic insights help guide clinical decisions.

• Real-time PCR assays and multiplex panels enable direct pathogen detection, with options to test for multiple targets simultaneously and select the most appropriate panel for the clinical presentation and sample type.
• DTprime II is a next-generation qPCR platform for qualitative and quantitative analysis, offering multiplex testing, automated reporting and LIS integration.
• ELISA assays for infectious diseases provide a range of options for serological testing.

Rapid tests for everyday clinical practice.

• Beright Bordetella pertussis detects antigens of the bacterium that causes whooping cough in 15 minutes.
• Intec Rapid Flu A/B Test detects and differentiates influenza A and B in 3–5 minutes.
• VBM13 Respiratory 13 Pathogen simultaneously detects and differentiates 13 respiratory pathogens, delivering results within 12 minutes.
• CRP & MxA Combo measures two biomarkers to help differentiate viral from bacterial respiratory infections.

Date: November 6–8, 2026

Venue: NCIPD Auditorium, Sofia

We look forward to welcoming you to the RIDACOM exhibition area to explore the diagnostic aspects of vaccine-preventable diseases, discuss how different methods complement one another and consider the information they provide at each stage of the diagnostic process.

For further details visit the official conference website.